Not only the research and development of traditional ADCs continues to be hot, but various new drug conjugates (NDCs) are also blooming. In this article, we make statistics on the research and ...

The chimeric antigen receptor T (CAR-T) cell therapy from ACROBiosystems is a new treatment developed for a range of cancers. The concept is to take the T-cells from the patient and genetically ...

Researchers from Longhorn Vaccines & Diagnostics LLC have presented data at the ongoing ESCMID conference regarding their unconjugated multiepitope vaccine against influenza, LHNVD-105.

and KSI-101 (KSI-501P), an unconjugated bispecific protein targeting IL-6 and VEGF developed for retinal inflammatory conditions. The company was formerly known as Oligasis, LLC and changed its ...

Expert Rev of Obstet Gynecol. 2012;7(3):269-279. In summary, excess levels of urobilinogen and bilirubin in the urine may signal liver disease, and more research is needed to correlate these ...

Unlock the potential of adaptive immunity with ImmuneSelect by Virax Biolabs. Investigate T-Cell driven immunity for post-viral syndromes like Long COVID. Explore peptide pools and recombinant ...

The data will be presented in oral session at the 2024 American Society of Gene & Cell Therapy meeting May 7-11 in Baltimore, ...

There are two types, including an indirect (unconjugated) version that travels through the blood to the liver, where it's then changed into the direct (conjugated) type. For most people, that latter ...

Lower Limit of Detection (LLOD) Versus Lower Limit of Quantification (LLOQ) The LLOD is the HCV RNA concentration at which less than 5% of the samples that contain a known amount of an RNA ...

(NYSE: PFE) announced today the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for TIVDAK ® (tisotumab vedotin-tftv) for the treatment of ...

Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, presented positive data from three key studies of its ...